ArcView Market Research

On Oct. 17, 2018, Canada made history by becoming the first G7 country and the second country overall to legalize adult-use cannabis. Yet the rollout of legal Canadian cannabis was fraught with shortages, a limited retail presence and poor product selection.  In 2018, legal cannabis...

Acreage Holdings Inc (OTC: ACRGF), the largest vertically integrated, multistate owner of cannabis licenses and assets in the U.S., said Wednesday it would enter the California dispensary market through the acquisition of Kanna. The announcement follows the company reporting its fiscal fourth-...

At the end of the first quarter of 2018, we spoke with GreenWave Advisors’ Matt Karnes, who said California cannabis sales could hit $2.5 billion in 2018, mostly in line with estimates out of BDS Analytics and Arcview Market Research. Now that a year has passed since recreational...

Canada is buzzing after the legalization of recreational cannabis, with long lines at the few retailers already open, a supply shortage, impaired driving fears, people taking to the streets in joy ...  But what does legalization mean for the Canadian economy? How much is the market...

A shortened week brought less cannabis news than usual, providing the people in the industry with a chance to exhale and look back at the convoluted weeks leading up to the Fourth of July holiday.  We did witness some relevant action. Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) reported...

Almost every week, an American or Canadian cannabis company announces a large overseas investment. And it's no longer just Germany, Israel and Australia that are piquing investors’ interest. Emerging markets like Jamaica are also turning heads. The largest investment opportunities might...

April started with considerable pressure on the markets. “Concerns over legalization in Canada, previously assumed to be a ‘done deal,’ continue to weigh on investors, along with fears of a supply glut, as discussed on the cover of Barron’s this week,” 420 Investor...

It was a turbulent week for cannabis stocks in the U.S., however, it was Canadian equities that experienced the most volatility, largely due to the publication of Health Canada’s document on legal cannabis packaging, marketing and retail, and the later vote of Bill C-45, also known as ...

This was a strange week for cannabis stocks, as major indices experienced a plateau, spiking Tuesday and tumbling Thursday. The United States Marijuana Index, which tracks 15 of the largest marijuana stocks in the U.S., ended the week down 4.1 percent, while the North American Marijuana Index,...

Despite a strong performance Friday, U.S. cannabis stocks had a bad week, with the United States Marijuana Index, which tracks 15 of the largest marijuana stocks in the U.S., losing roughly 4 percent of its value. The North American Marijuana Index, which also includes Canadian stocks, shed...